CC260 is a selective small-molecule inhibitor of PI5P4Kα and PI5P4Kβ used in research on cellular energy metabolism, diabetes, and cancer. The compound demonstrates low-nanomolar potency, high chemical purity, and is supplied with solubility and storage guidance suitable for in vitro and in vivo studies.
- Selective inhibition of PI5P4Kα and PI5P4Kβ.
- Potent binding (Ki ~40 nM and ~30 nM).
- High purity (99.45%).
- Soluble in DMSO at high concentration for in vitro use.
- Formulation guidance provided for in vivo studies.
- Recommended storage conditions for powder and solutions.